All posts by imreal

a new mindset to address the obesity epidemic and beyond


Positive Nutrition: People do not eat nutrients. People eat foods and they do so in complicated dietary patterns as well as in astonishingly complex external environmental circumstances.

Nutritional science and nutritional policy cannot continue to ignore the interactions among diet, environment, lifestyle, and health maintenance – Dennis Bier, MD

The Mediterranean Diet Roundtable® in collaboration with the Embassy of Italy, Cambridge Food Science, and the American Italian Food Coalition, cordially invite you to the symposium: “Positive Nutrition: Shifting the Focus from Nutrients to Diet for a Healthy Lifestyle,” to be held on Thursday, September 15, 2022, from 3:30 to 5:30 pm at the Embassy of Italy in Washington, DC (3000 Whitehaven Street NW, Washington, DC 20008), with a reception to follow. H.E. Mariangela Zappia, Ambassador of Italy to the United States, will give opening remarks.

The impact of dietary choices on human health is gaining undivided attention, with an urgent call to action for developing new strategies able to contrast weight-related diseases as well as poverty. This symposium aims to provide an inclusive approach to adopting positive nutritional strategies, focusing on the long-term results and not on specific nutrients, moving the narrative to the whole lifestyle: sustainable dietary patterns, physical, and social activity as agents of change.

Since Hippocrates, food, and medicine have been interlaced in many ways. But now more than ever, it is imperative to better understand these complex relationships, with a multidisciplinary approach able to create a cohesive relationship between food, nutrition, environment, economic, social, and policy aspects, creating a new narrative about eating patterns.

With the discovery of essential nutrients in the first half of the 20th Century, nutritionists began employing relatively short- or intermediate-term experiments for disease prevention. However, fad diets never contemplate the whole picture: e.g.: people eat complex foods, not individual nutrients; observational studies are unable to determine causality; there are serious difficulties in designing, implementing, and funding long-term intervention trials.

A general scientific consensus endorses the Mediterranean eating pattern, its food matrix, lifestyle and societal variables, and environmental conditions contributing to long-term well-being. One result of such scientific investigations highlights the importance of avoiding stigmatizing this or that ingredient, and to focus on the whole meal and the right portion: a distinctive feature of the Mediterranean Diet as well as other traditional eating patterns.

Building on this science-based perspective, speakers at this symposium will discuss how public policy can help support whole diets, physical activity, and associated lifestyles.

Featured world-class scholars in the program include:


  • Dennis Bier, Director of the USDA/ARS Children’s Nutrition Research Center at Baylor College of Medicine (USA)
  • Hugo Da Costa Ribeiro, Federal University of Bahia (Brazil)
  • Lorenzo Maria Donini, University La Sapienza (Italy)
  • Paul Gately, Leeds Beckett University (UK)
  • Daniela Martini, University of Milano (Italy)
  • Rick Mattes, Perdue University (USA)
  • Roberta Re, Director at Cambridge Food Science (UK) and Scientific Chair of the event

The program will be organized in two sessions: Importance of Diets not individual ingredients – European and American Dietary Pattern: Nutrition/Nutrients/ Mediterranean Diet; followed by The Role of Portion in Dietary Pattern: Energy balance, physical activity, portion size, and frequency of consumption.

“Nutritional science and nutritional policy cannot continue to ignore the interactions among diet, environment, lifestyle, and health maintenance,” says Dennis Bier adding “In order to illuminate the full nutritional field for the future, we must shine a light on all those variable interdependencies and their contributions to causal relationships among diet and disease prevention.” Roberta Re, Scientific Chair of the event states: “Dietary recommendations have promoted a restriction approach for several years, meanwhile level of obesity has continued rising across the globe. Are we tackling the problem with the right tools? A complex and multifaced problem such as obesity cannot be simplified to a single solution.”

Additional information about the speakers can be found by visiting http://www.MDRproject.com Interested Media please RSVP to: info@MDRproject.com

Share article on social media or email:

ARHS Implementing MEDI+SIGN Technology Into Watauga Medical Center Expansion


Appalachian Regional Healthcare System Watauga Medical Center Expansion

Appalachian Regional Healthcare System Watauga Medical Center Expansion

“It is exciting to see technology helping to keep patients and families better informed about care… MEDI+SIGN will also help staff with making sure that care boards are automatically updated in real-time…” – Greg Miller, Chief Nursing Officer at Watauga Medical Center.

Read the full article on the ARHS website here: https://apprhs.org/expansion-project-brings-new-technology-to-patient-care/

Appalachian Regional Healthcare System (ARHS), located in Boone, North Carolina, is expanding its Watauga Medical Center with a $126 million construction project. Technological enhancements include the implementation of MEDI+SIGN Digital Whiteboards and MED+SIGN Digital Door Displays, aligning with ARHS’s focus to deliver premier healthcare.

“For years, ARHS has successfully worked around limitations in space and declining buildings that have kept us from achieving our full potential. It’s time we invest in people, systems, and facilities. This will expand our opportunities and position us for the future,” said Chuck Mantooth, President and CEO of Appalachian Regional Healthcare System.

After 60 years of dedication to the community, ARHS is committed to improving its entire operation from the inside out. This 100,000 sq. ft. hospital expansion includes surgery, imaging, bed replacement, and a new Central Energy Plant.

A new four-floor, 48-bed tower will provide larger patient rooms capable of accommodating high-tech mobile medical equipment, state-of-the-art surgical suites, an updated Emergency Department, new waiting areas, and more. A new two-story entryway will greet patients with natural light and serene mountain images as they enter the building.

Along with the new building comes a whole new era of technology advancement at Watauga Medical Center. One prominent feature will upgrade patient rooms with automated and real-time digital in-room and door displays to elevate the patient experience while also improving staff and patient communication, satisfaction, and safety.

“It is exciting to see technology helping to keep patients and families better informed about care. The product also adds safety with real-time warnings for patients who may be attempting to leave the bed by providing visual and audio warnings. MEDI-SIGN will also help staff with making sure that care boards are automatically updated in real-time with automatic data flows from the electronic medical record,” said Greg Miller, Chief Nursing Officer at Watauga Medical Center.

“To support their mission to provide high quality, compassionate healthcare, Watauga Medical Center has installed MEDI+SIGN, fully integrated, digital in-room and door displays. This state-of-the-art technology is located in the patient rooms, including ICU, Orthopedics, Med-Surg, Labor and Delivery, and the Emergency Department,” says David Linetsky, Founder/CEO of MEDI+SIGN. “The MEDI+SIGN electronic patient room whiteboards replace the traditional dry-erase boards in the patient rooms to focus on communication enhancements while substantially reducing the staff workload. The staff-facing door displays provide an overview of the patient’s care plan, risks, and other precautions to the healthcare team. Clear and concise information on the MEDI+SIGN Emergency Department Whiteboards highlights items such as tests ordered, average turnaround times and lab status.”

The MEDI+SIGN solution fully integrates with Allscripts®, ARHS’s electronic medical record (EMR), to display the patient’s real-time healthcare data to clinicians, patients, and their families. MEDI+SIGN also uses data from ARHS’s Real-Time Locator System (RTLS), to support rounding initiatives, providing peace of mind to the patient and family.

MEDI+SIGN focuses on improving HCAHPS and ensuring the utmost patient safety by reducing falls and other sentinel events. Watauga Medical Center’s smart beds integrate with MEDI+SIGN ANTI-FALL™ technology to alert healthcare staff, patients and families of potential fall risks by sending alerts to the digital whiteboards in the patient’s room and in the hallway. Patent-pending algorithms use the information in the patient’s electronic health record to detect the patient’s fall risk and other factors to determine if the smart bed is in its safest position.

About Appalachian Regional Healthcare System

Appalachian Regional Healthcare System (ARHS), the leader for healthcare in the High Country, is comprised of two hospitals, thirteen medical practices, Seby B. Jones Regional Cancer Center, The Rehabilitation Center, The Breast Center and the Paul H. Broyhill Wellness Center. Appalachian Regional Healthcare System stays committed to promoting health in the High Country, enhancing quality of life and simply “making life better.“ Visit https://apprhs.org/ to learn more.

About MEDI+SIGN

MEDI+SIGN is a game-changing communication tool used by hospitals that are pursuing the creation, improvement, and sustainability of their quality and safety goals. Driven and perfected by evidence-based outcomes, MEDI+SIGN deploys strategies tailored to the hospital’s specific needs and existing workflows. This unique approach allows hospitals to experience quality and safety transformations without negatively impacting the day-to-day workflow of staff. MEDI+SIGN is the first and only patient-facing technology in its class that requires zero effort from clinical staff while reinvesting time back to the bedside. With patient experience and complex psychology at the epicenter of this technology, patients are kept informed, satisfied, and safe. Beyond patient experience, MEDI+SIGN focuses on improving HCAHPS and increasing patient safety by preventing falls as well as other sentinel events related to HAC, among other CMS programs. To experience these results for yourself, visit https://medisigndisplays.com.

*Allscripts is a registered trademark of Allscripts Healthcare LLC

MEDI+SIGN is a registered trademark. © 2022 MEDI+SIGN® All Rights Reserved

Share article on social media or email:

Adam Grant, Organizational Psychologist and Bestselling Author to Keynote PCMA’s 2023 Convening Leaders in Columbus


Adam Grant, an organizational psychologist and bestselling author, will deliver a keynote at PCMA’s annual Convening Leaders event on Jan. 9, 2023.

“Through our phenomenal lineup of speakers like Adam Grant and our three days of immersive programming and networking, Convening Leaders 2023 will inspire and challenge participants and prepare us to navigate the headwinds of today and tomorrow.” — PCMA President and CEO Sherrif Karamat, CAE

Adam Grant, an organizational psychologist and bestselling author who explores the science of motivation, generosity, original thinking, and rethinking will deliver an opening day keynote on Monday, January 9, 2023, at PCMA’s annual Convening Leaders. The theme of the association’s flagship education and network event is Ignite Your Path, and will take place at the Greater Columbus Convention Center in Columbus, Ohio in partnership with Experience Columbus.

Grant is an organizational psychologist at Wharton, where he has been the top-rated professor for seven straight years. A #1 New York Times bestselling author, his books have sold millions of copies and been translated into 35 languages. His pioneering research has inspired people to rethink fundamental assumptions about motivation, generosity and creativity. He has been recognized as one of the world’s 10 most influential management thinkers and Fortune’s 40 under 40 and has received distinguished scientific achievement awards from the American Psychological Association and the National Science Foundation.

Convening Leaders 2023 is an incubation and experiment where the best in content, commerce, community, and experience come together to create new value for all participants and the business events industry. Industry trailblazers — the fighters, finders and inventors who are on a quest to move our industry and society forward will be featured.

Grant’s keynote, “Originals: How Non-Conformists Move the World” will reveal how to recognize and champion new ideas and build cultures that welcome diverse perspectives and honest feedback.

“We live in a time that presents a new set of challenges for the industry — uncharted territories, unknown opportunities and perils, and unsolved problems,” says PCMA President and CEO Sherrif Karamat, CAE. “This is the time for us to challenge our own thinking, embrace data and new experiments to increase value. Through our phenomenal lineup of speakers like Adam Grant and our three days of immersive programming and networking, Convening Leaders 2023 will inspire and challenge participants and prepare us to navigate the headwinds of today and tomorrow.”

Columbus is recognized as an innovation center that is consistently ranked as one of the United States’ top cities to visit and is the 14th largest city in the United States. The destination is home to some of the world’s most recognizable brands, innovative small businesses, powerhouse research hubs and academic institutions. In January, Intel — the only major semiconductor manufacturer headquartered in the U.S. — chose the Columbus Region for a $20B chip production facility that will open in 2025. The region is also home to 16 Fortune 1000 companies and five Fortune 500 companies and has one of the youngest and most educated populations in the country.

“Columbus is experiencing unprecedented growth and has a vibe unlike any other city,” notes Brian Ross, Experience Columbus President and CEO. “Here, our approach is different. ‘The Columbus Way’ is a phrase often used to describe our unique community collaborations between the city, the businesses headquartered here and our nonprofit and academic institutions. It’s because of this unified approach that we can offer such an unparalleled level of service to the meetings and conventions that come to Columbus. We can’t wait to roll out the red carpet and welcome Convening Leaders participants to our smart, open and forward-thinking city.”

Participants can learn more about Columbus and what to expect at Convening Leaders during a special episode of Live Forward Live, an Experience Columbus podcast. Now in its third season, the first episode of a new PCMA series features Karamat in conversation with City of Columbus Mayor Andrew J. Ginther. Tune in to learn why PCMA chose Columbus, what experiences await attendees in January and Karamat’s prediction on where the industry is headed.

Registration is now open for members through September 11, 2022. General registration will open Sept. 12. Learn more about PCMA Convening Leaders at conveningleaders.org.

Share article on social media or email:

US Fertility welcomes Quinton Katler, M.D., M.Sc., to the Shady Grove Fertility Atlanta physician team


Dr. Quinton Katler is now accepting new patient appointments at SGF Atlanta’s Northside location.

“SGF constantly raises the bar industry-wide for fertility-related healthcare on every level and has fantastic pregnancy rates to show for it. I’m extremely proud to begin serving alongside the SGF Atlanta care team to provide patient-centered fertility care.”

US Fertility, the largest physician-owned and physician-led, integrated network of top-tier fertility practices in the United States, welcomes Quinton Katler, M.D., M.Sc., to Shady Grove Fertility’s Atlanta – Northside location. Dr. Katler is now accepting new patient appointments.

“I have long understood that there is nothing more important in life than family,” shares Dr. Katler. “As such, helping individuals and couples build the family of their dreams is a dream come true. SGF constantly raises the bar industry-wide for fertility-related healthcare on every level and has fantastic pregnancy rates to show for it. I’m extremely proud to begin serving alongside the SGF Atlanta care team to provide patient-centered fertility care.”

Dr. Katler will provide comprehensive fertility services, including:


  • fertility and ovarian reserve testing and diagnosis,
  • semen analysis,
  • hysterosalpingogram (HSG),
  • low-tech fertility treatment options such as intrauterine insemination (IUI),
  • in vitro fertilization (IVF),
  • donor egg, sperm, and embryo,
  • genetic screening and testing,
  • gestational carrier,
  • egg freezing,
  • fertility preservation for patients with cancer, and
  • LGBTQ+ family building.

Dr. Katler is board certified in obstetrics and gynecology (OB/GYN) and board eligible in reproductive endocrinology and infertility (REI). Dr. Katler earned his medical degree from the American Medical Program at Tel Aviv University in Tel Aviv, Israel. He then completed his residency in OB/GYN at George Washington University in Washington, D.C. From there, Dr. Katler trained in REI at Emory University in Atlanta, Georgia.

As an avid researcher, Dr. Katler has contributed to numerous publications, presentations, and committees exploring such topics as LGBTQIA+ family-building, recurrent pregnancy loss, egg freezing, and infertility care for marginalized communities, among others. He is a member of several professional organizations, including the American Society for Reproductive Medicine (ASRM), the American College of Obstetricians and Gynecologists (ACOG), and the Society of Reproductive Endocrinology and Infertility (SREI).

“We are thrilled to add Dr. Katler to the SGF Atlanta medical team,” shares Desireé McCarthy-Keith, M.D., M.P.H., medical director of SGF Atlanta. “His energetic approach to patient care is one of kindness, empathy, and full transparency, which directly aligns with SGF’s patient-centered fertility care model.”

Patients may now schedule a new patient appointment with Dr. Katler by calling 404-419-7141 or by submitting this brief form.

About US Fertility

US Fertility is the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit USFertility.com.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 48 locations, including new locations in Texas, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Share article on social media or email:

Mount Sinai Researchers Report Encouraging Immunotherapy Option for Relapsed Myeloma Patients


“This study shows patients relapsing after initial bispecific antibodies therapy can benefit from a second bispecific antibody or CAR-T cell therapy.” -Samir Parekh, MD

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time—they are meant to enhance the immune system’s destruction of tumor cells.

While new T cell-based immunotherapies, or “T-cell redirection” therapies, such as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies have revolutionized cancer treatment, doctors still need to determine what second-line treatments (also known as salvage therapy) are effective after a patient relapses. In the August 26 online edition of Blood Advances , Mount Sinai researchers report that sequential use of different T-cell redirection therapies in these multiple myeloma patients is possible and could lead to good patient outcomes and survival.

In a retrospective analysis, researchers identified 58 multiple myeloma patients who participated in a bispecific antibodies clinical trial at Mount Sinai and underwent salvage therapy due to relapse. Patients were followed for an average of 30.5 months after the end of the trial and underwent an average of two salvage therapies over that period.

Nineteen patients received T-cell redirection therapy as a first salvage therapy, and the rest received a non-T-cell redirection therapy, such as chemotherapy. Thirty-two percent of patients who underwent T-cell redirection therapy as a first salvage therapy needed to undergo a second salvage therapy due to relapse or nonresponse to therapy. In a significant contrast, 79 percent of the patients treated with a non-T-cell redirection therapy needed to undergo a second salvage therapy. Some of this group of patients had T-cell redirection therapy as their second salvage therapy, resulting in a total of 28 patients who received T-cell redirection as either a first salvage therapy or second salvage therapy.

Depth and duration of response to the first bispecific antibodies treatment did not predict response to the second T-cell redirection therapy, indicating that even if patients did not respond to an initial T-cell redirection therapy, there may still be an option to effectively treat with a second course. The overall response rate of the 19 patients who transitioned from the initial bispecific antibodies to T-cell redirection therapy as a first salvage therapy was 84 percent, compared to 49 percent in those who received other types of therapies.

“As the clinical use and advancement of T-cell redirection therapies continue to grow, effective strategies are needed to manage outcomes for patients who relapse or are unresponsive to this initial treatment,” said senior author Samir Parekh, MD, Director of Translational Research in Myeloma, co-leader of the Cancer Clinical Investigation program at The Tisch Cancer Institute, and a member of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai. “This study shows patients relapsing after initial bispecific antibodies therapy can benefit from a second bispecific antibody or CAR-T cell therapy.”

Studies are underway to understand how T cells function after initial T-cell redirection therapy and how they are activated in sequential bispecific antibodies and CAR-T cell treatments. “Future clinical trials incorporating sequential combinations of T-cell redirection therapy will build upon these findings to further develop treatment guidelines and improve long-term outcomes for multiple myeloma patients,” Dr. Parekh said.

This work was supported by the National Cancer Institute (NCI) R01 CA244899 and CA252222.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.

Share article on social media or email:

Vibrant Nutraceuticals Launches New Performance Bundles to Save 20% on Three Products to Maximize Workouts


News Image

“It’s easy to get overwhelmed by the sheer amount of workout supplements on the market. The Flex Fit Pro Performance Bundle takes the guesswork out of finding support for your muscles, joints, and cartilage by putting it all in one place,” said Jim Rex, President of The GHT Companies.

Vibrant Nutraceuticals, part of The GHT Companies’ family of brands, has just released their newest bundle: the Flex Fit Pro Performance Bundle. The bundle includes Flex Fit Pro Whey Isolate Protein Powder, Silica Plus for ligament health and connective tissue flexibility, and Joint Muscle Plus for joint maintenance and support. These all-natural supplements are Non-GMO, Gluten-Free, Cruelty-Free, and contain no artificial colors or sweeteners.

The Flex Fit Pro Bundle comes with full servings of Silica Plus and Joint Muscle Plus, as well as a full serving of one of two Whey Isolate Protein flavor options: decadent Chocolate Milkshake or dreamy Angel Food Cake. The Flex Fit Pro protein powder is sweetened with Stevia extract, satisfying your dessert cravings and supporting your health goals with 27g of protein, less than 2g carbs, and 1g fat per serving.

Not only is it great for your health, but it helps your wallet, too! You save 20% when you purchase the Flex Fit Pro Performance Bundle instead of the 3 individual supplements.

“We are excited to launch the Flex Fit Pro Performance Bundle because it’s an all-in-one approach for healthy muscle and joint support,” said Jim Rex, President of The GHT Companies. “For people who live an active lifestyle, it’s easy to get overwhelmed by the sheer amount of workout supplements on the market. The Flex Fit Pro Performance Bundle takes the guesswork out of finding support for your muscles, joints, and cartilage by putting it all in one place,” Rex added.”

These Bundles are ideal for people who maintain an active lifestyle as the wear and tear on joints, muscles, cartilage, and ligaments is common with high volumes of physical activity. Vibrant Nutraceuticals recommends that active adults take one scoop of the Flex Fit Pro Performance Whey Isolate protein before or after a workout, ¼ tsp of Silica Plus each day, and 1 fluid ounce of Joint muscle plus a day.

———————————————————————————————————————

About Vibrant Nutraceuticals

We are the trusted source for nutraceutical innovation, formulating some of the most cutting-edge wellness solutions on the market. Our unique line of supplements is both inclusive and affordable, working in conjunction with physician guidelines to meet your health needs – no matter your age, life stage, or walk of life. We strive to empower you on your journey, helping you achieve your personal wellness goals and paving the way to better health.

At Vibrant Nutraceuticals, our goal is achieving excellence, both in your quality of life and in the quality of our supplements. Each product is formulated from only the safest, highest-quality ingredients with the strictest standards. Our founding scientists, internal science team, and in-house manufacturing team work tirelessly to ensure that our products are as effective as they are convenient. We are constantly innovating, so you can be sure that your favorite products are made from the latest and greatest ingredients for years to come.

About The GHT Companies

The GHT Companies is one of the most trusted names in the nutritional supplement field since 1996. The group is structured to collaborate with founding scientists to develop their unique ingredient/product discoveries and to deliver industry-leading, high-quality consumer products and ingredients on a global basis.

The GHT Companies uses its unique business structure of 5 diverse subsidiaries that touch on all facets of the nutraceutical industry in order to provide products and services to customers in the most effective way possible.

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Information and statements made are for educational purposes and are not intended to replace the advice of your health care professional.

Share article on social media or email:

Beyond Clean and U.S. Career Institute Partner to Solve Sterile Processing Employment Shortages through Education and Customized Recruiting


“This program finally provides a proven strategy that can not only fill those critical Sterile Processing roles, but also leverages our hospital’s investment back into our department to develop depth of expertise and greater retention.”

Beyond Clean, a leading provider of Sterile Processing education and consulting and U.S. Career Institute, an online educator, today announced the strategic initiative Beyond Clean Powered by U.S. Career Institute. This collaborative effort supports Sterile Processing departments across the U.S. in solving employment shortages through education and customized recruiting.

This collaboration will help employers achieve their Sterile Processing Department staffing needs. Beyond Clean powered by U.S. Career Institute will train high-quality, certified Sterile Processing technicians, assist Sterile Processing departments find their next employees and retain their current employees through creative, customized solutions that include geo-targeted, co-branded talent acquisition campaigns, resume review and applicant screening, and develop career ladders through certification and micro credentialing to keep their best and brightest talent.

Hank Balch, Founder and President of Beyond Clean, recently gathered data through an August 2022 LinkedIn poll showing a startling 62% of industry respondents have 3+ vacancies in their Sterile Processing departments, with a full 38% stating they had 5+ vacancies across their team. “”Historically our industry’s default ‘solution’ for a staffing crisis or long-term vacancy has been to pay outside temporary staff a premium to step into our departments for a limited time to keep surgeries churning,” says Balch. “This program finally provides a proven strategy that can not only fill those critical Sterile Processing roles, but also leverages our hospital’s investment back into our department to develop depth of expertise and greater retention.”

Earl Weston, Owner and President of U.S. Career Institute, stated, “Understaffed and Undertrained Sterile Processing Departments have the potential to cause disruption within our healthcare systems. Sterile Processing Technicians are unsung heroes working diligently behind the scenes to ensure patient safety every day! They ensure every instrument is clean, sterile, and up to standards to go into the OR every time. Patient safety must be at the forefront of our healthcare systems, and without Sterile Processing Technicians doing their job at the highest-level, rates of infection within our healthcare systems will increase. These are tall orders and add to that understaffing in many Sterile Processing departments across the U.S., it is clear we must find solutions to attracting, developing, and retaining staff in this highly specialized and very important career field. U.S. Career Institute is proud to be part of the solution to keep our healthcare systems operating timely and safely.”

For more information, visit https://educate.beyondclean.net/usci or call (970) 207-4432.

About U.S. Career Institute

Weston Distance Learning, the parent company of U.S. Career Institute, has been providing distance education since 1981. By offering high-quality, career-focused online education at affordable prices, U.S. Career Institute has helped thousands of students reach their educational and career goals. U.S. Career Institute is accredited by the Distance Education Accrediting Commission (DEAC), which is listed by the U.S. Department of Education as a recognized accrediting agency. USCI’s curricula, administrative procedures, faculty, and policies are frequently reviewed to make sure that USCI continues to meet high standards of quality and service. To learn more about U.S. Career Institute, visit https://www.partners.uscareerinstitute.edu/

About Beyond Clean Partners, LLC

Beyond Clean is a next generation Sterile Processing education, media, and consulting company with a commitment to being the central nexus for the people, processes, and products that are pushing the Sterile Processing industry forward. With a combined 120+ years of healthcare experience, the team at Beyond Clean brings cutting-edge insight and expertise to our partners. We are internationally certified Sterile Processing subject matter experts and clinical innovators with a passion to #FightDirty. To learn more visit https://www.beyondclean.net

Share article on social media or email:

Successful Implant Rehabilitation After Partial Removal of the Mandible Due to ACC


Journal of Oral Implantology Volume 48 Issue 3

The complicating factor for dental implant treatment in these cases is the bone health after therapeutic doses of ionizing radiation

Journal of Oral Implantology – Oral cancer can have a detrimental impact on a patient’s quality of life, causing issues with jaw structure, chewing, eating, and overall discomfort. Severe forms of cancer, such as adenoid cystic carcinoma (ACC)—a rare form of salivary gland malignancy that can spread to the breast, skin, respiratory system, and reproductive organs—create major complications for dental health practitioners due to the aggressive nature of the cancer therapies. ACC treatment plans typically involve surgery and radiotherapy which weaken the jaw and lead to malformation, caries, and lost teeth.

“The complicating factor for dental implant treatment in these cases is the bone health after therapeutic doses of ionizing radiation,” pens Tirakhsh Emadi, DDS, out of a private practice in Dallas, Texas, as well as co-authors from Nova Southeastern University College of Dental Medicine, Davie, Florida. Emadi and colleagues recently published a novel case report in the Journal of Oral Implantology that outlines the successful implant rehabilitation after partial removal of the mandible due to ACC.

A 57-year-old Black woman presented with an inability to eat, open her mouth widely, and extreme discomfort in her mandibular teeth. The patient received a combination of multiple oral surgeries for tumor removals and radiotherapy from being diagnosed at age 24 with ACC, then again with recurring diagnoses and similar treatments at ages 34 and 47. Given the patient’s extensive surgical history and radiotherapy, the treatment plan included removal of the remaining teeth, dental implant insertions, and a removable prosthesis in the mandibular arch, requiring substantial oral rehabilitation.

Before beginning treatment, consultation with a radiation oncologist was imperative to ensure radiation exposure did not spread throughout the mandible and that there was enough solid bone to move forward. The patient’s treatment plan was verified and began with one tooth extraction and implant placement. The healing process yielded no complications, and treatment proceeded with removing the subsequent teeth and implant placements. The placement of the removable prosthesis occurred after a three-month rehabilitation period. The patient had a follow-up appointment three months later with imaging showing proper healing, and “the patient reported that she was so satisfied with the mandibular rehabilitation, that she kept the prosthesis in place even during sleep since it stabilized her mandible for all-day and all-night comfort.”

This case report shows that oral cancers, especially aggressive and recurring cancers like ACC, can harm a patient’s quality of life. However, successful reconstructive surgery is possible with appropriate collaborative care and a thorough understanding of the patient’s history. Regarding the importance of this case report, co-author Jack Piermatti, DMD, states that “it highlights the topic of oral malignancy and the restoration of comfort and function for patients. Although this article features a case of ACC of the submandibular salivary gland, any malignancy involving the oral and maxillofacial area can be devastating for the patient. After complete removal of the lesion and surgical reconstruction of the mandible, prosthodontic specialists can combine disciplines of implantology and prosthetic restoration for the return of a satisfactory quality of life for patients with these malignancies.”

Full text of the article, “Implant Rehabilitation After a Partial Resection of the Mandible Resulting from Submandibular Gland Malignancy—A Case Report” Journal of Oral Implantology, Vol. 48, No. 3, 2022, is available at https://doi.org/10.1563/aaid-joi-D-21-00086

###

About the Journal of Oral Implantology

The Journal of Oral Implantology is the official publication of the American Academy of Implant Dentistry and of the American Academy of Implant Prosthodontics. It is dedicated to providing valuable information to general dentists, oral surgeons, prosthodontists, periodontists, scientists, clinicians, laboratory owners and technicians, manufacturers, and educators. The JOI distinguishes itself as the first and oldest journal in the world devoted exclusively to implant dentistry. For more information about the journal or society, please visit http://www.joionline.org.

Media Contact:

Samantha Weinkauf

Allen Press, Inc.

785/865-9123

sweinkauf@allenpress.com

Share article on social media or email:

OSDB Partners with Big Al Taking the Next Step in the Venture and Offering Sports Handicapping


News Image

Online Sports Database or OSDB was founded in 2021 by future hall-of-fame quarterback Aaron Rodgers and current CEO and actor Ryan Rottman. The goal of OSDB was simple; to create an extensive database detailing the lives of professional athletes with unprecedented granularity. OSDB prides themselves on the amount of detail and comprehensive nature with which they cover high-profile professional athletes and teams. Each athlete on OSDB has their own profile on which fans can find out more about their personal lives like their hobbies, interests, endorsement deals and ventures outside of their athletic ones, and even their charitable works and initiatives.

Despite being founded by an NFL quarterback, OSDB isn’t a football-exclusive database. Currently OSDB features complete databases across the NFL, NBA, MLB, and MLS. Additionally, they’re working on adding more sports to their platform as well. Beyond these databases and player-profiles, OSDB also produces original editorial content that celebrates athletes for all they do on and off the field.

Recently OSDB took a big step forward by taking advantage of an opportunity to partner with one of the most well-established names in the world of sports betting, Big Al. BigAl.com is partnering with OSDB to offer sports handicapping.

The partnership has OSDB CEO, Ryan Rottman absolutely thrilled for the future of OSDB, “We’re really excited to partner with Big Al. Al has a solid, reliable presence with a lot of integrity which is key in the handicapping space. His transparency, knowledge of sports and track record make him one of the best in the business.”

The partnership between OSDB and BigAl.com brings about a new era of sports-content that will forever change the way fans consume sport and sport-betting content.

Share article on social media or email:

Breast Cancer Stories Podcast Launches 2nd Season to Help Newly Diagnosed Women


Told in real time, Breast Cancer Stories is “a treasure trove of thoughtful and insightful information, for those of us going through this, partners, caregivers, friends…blended with stories from two delightful women who feel like friends within just a few episodes.”

Two friends from Austin are helping thousands of women with a podcast about the raw, unfiltered realities of breast cancer.

To recover from a career-ending workplace trauma, 56-year-old Kristen Vengler left her home of 26 years in Austin hoping for a fresh start in San Diego. Just a few months later in the shower, she discovered her own tumor and suddenly she was facing a Stage 3b breast cancer diagnosis.

“The only way I could get through this was to focus on helping others,” said Vengler, who has been cancer free since June of 2021.

Around the same time, longtime healthcare marketer and friend Eva Sheie started The Axis, a healthcare podcast production company. Sheie suggested that Vengler share her story on a podcast to help inform her friends and family throughout the stages of breast cancer treatment. They began recording her story on the first day of chemotherapy and continued through her double mastectomy, radiation, and breast reconstruction.

Told in real time, the Breast Cancer Stories podcast launched in September of 2021. Thank you messages poured in as others in the same situation began responding to the podcast, saying things like ”the best out there… a treasure trove of thoughtful and insightful information, for those of us going through this, partners, caregivers, friends…blended with stories from two delightful women who feel like friends within just a few episodes.” This inspired Vengler and Sheie to expand their mission and help others through the shock of diagnosis and treatment.

The second season launches August 25, 2022 featuring Natasha Curry, a palliative care nurse practitioner at San Francisco General Hospital.

While in Malawi on a Doctors Without Borders mission in 2021, Natasha’s husband of 25 years announced in a text message that he was leaving. She returned home, fell into bed for a few weeks, and eventually with the help of her friends she pulled herself together and went back to work.

A few months later when she discovered an almond-sized lump in her armpit, she did everything she tells her patients not to do and dismissed it, or wrote it off as a “fat lump.”

Months went by before Natasha finally got a mammogram, but radiology saw nothing in either breast. It was the armpit lump that caught their attention. One painful biopsy later, Natasha found out she had cancer; in one life-changing moment, the nurse became the patient.

The Breast Cancer Stories podcast is a shocking, sad, and often hilarious glimpse into the world of breast cancer diagnosis and treatment. In season 2, Vengler becomes the host of the podcast as Natasha’s story unfolds. It is available on Apple Podcasts, Spotify, and wherever you listen to podcasts.

About The Axis

Breast Cancer Stories is a production of The Axis, a creative agency specializing in storytelling through unique, high quality podcasts to build and grow highly engaged audiences for doctors, thought leaders, and healthcare industry professionals.

Contacts:


  • For sponsorship opportunities, guest appearances or media inquiries, contact The Axis at bcs@theaxis.io
  • Listen & follow on Apple Podcasts and hear the trailer
  • Subscribe to the newsletter

Share article on social media or email: